Skip to main content
Premium Trial:

Request an Annual Quote

University of North Texas Plans to use Illumina Sequencing in Forensics Projects

Premium

The University of North Texas Health Science Center's Institute of Applied Genetics and the Department of Forensic and Investigative Genetics will use Illumina's next-generation sequencing technology in several forensics projects.

The projects will include studies on forensically relevant genetic markers for human identity testing, pharmacogenetics for molecular autopsy, microbial forensics, and additional markers and methods to generate investigative leads in criminal cases and matters of national security.

The collaboration with Illumina will enable the center "to design sample preparation, analytical protocols, hardware, and software that expand the capabilities of forensic DNA analysts," Bruce Budowle, executive director of UNT's Institute of Applied Genetics and vice chair of the Department of Forensic and Investigative Genetics, said in a statement.

"Forensic biology methods can meet the demand and improve dramatically with the application of state-of-the-art sequencing technologies," he added.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more